BioRay Biotech-Creative Announces Expected Board Meeting Date for Q2 2026 Consolidated Financial Report

Announcement Date: August 1, 2026 Statement Date: July 31, 2026 Statement Time: 14:57:14 Company Code: 6955 Company Name: BioRay Biotech-Creative Subject: Announcement of the Expected Board Meeting Date for the Review of the Company's Q2 2026 Consolidated Financial Report Applicable Clause: Clause 31 Event Date: July 31, 2026 Details: 1. Board Meeting Notice Date: July 31, 2026 2. Expected Board Meeting Date: August 10, 2026 3. Financial Report or Self-Prepared Annual/Quarterly Financial Information to be Submitted to or Resolved by the Board: Q2 2026 Consolidated Financial Report 4. Other Matters to be Disclosed: None